MoonLake Immunotherapeutics header image

MoonLake Immunotherapeutics

MLTX

Equity

ISIN KY61559X1045 / Valor 118139749

NASDAQ (2025-12-24)

USD 13.87+0.95%

MoonLake Immunotherapeutics
UMushroom community rating:

4.00 2 votes No rating yet

NegativeNeutralPositive

About company

MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company focused on developing innovative treatments for inflammatory diseases. The company's primary asset is Sonelokimab, an investigational Nanobody® designed to target and treat inflammation more effectively. By leveraging advanced biotechnological approaches, MoonLake aims to improve patient outcomes in conditions characterized by chronic inflammation. The company is dedicated to advancing Sonelokimab through clinical trials to establish its efficacy and safety, positioning itself as a key player in the biopharmaceutical industry’s efforts to address unmet medical needs in inflammatory diseases.

Summarized from source with an LLMView SourceSector: Finance

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-73.7%1Y

38.7%3Y

%5Y

Performance

240%1Y

153%3Y

150%5Y

Volatility

884 M

Market cap (USD)

536,459

Daily traded volume (Shares)

55.19 / 52.6

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

4.00

2 votes

Performance:

4.50

Innovation:

4.00

Society:

4.00

Nature:

4.00

Alex Roberts

United Kingdom, 17 Dec 2025

Should've listened to this guy -->

Alex Roberts

United Kingdom, 20 Nov 2025

up 40% since I added a month ago, bounce back after potential lawsuit. Potential takeover looming

EQUITIES OF THE SAME SECTOR

First Horizon Corporation

First Horizon Corporation Valor: 1816537

Annual Return

-50%0%+50%

Risk level

110

-0.12%USD 24.51

Pandox AB

Pandox AB Valor: 28509822

Annual Return

-50%0%+50%

Risk level

110

0.50%SEK 199.60

SPIE SA

SPIE SA Valor: 28425996

Annual Return

-50%0%+50%

Risk level

110

-1.06%EUR 48.56

Ringkjobing Landbobank

Ringkjobing Landbobank Valor: 36852418

Annual Return

-50%0%+50%

Risk level

110

0.46%DKK 1,522.00

Sydbank A/S

Sydbank A/S Valor: 2097040

Annual Return

-50%0%+50%

Risk level

110

0.63%DKK 560.50

Ina Invest Ltd

Ina Invest Ltd Valor: 52402695

Annual Return

-50%0%+50%

Risk level

110

-0.85%CHF 23.30

Eurocommercial Properties NV

Eurocommercial Properties NV Valor: 113468330

Annual Return

-50%0%+50%

Risk level

110

-0.19%EUR 26.00

Kojamo Oyj

Kojamo Oyj Valor: 42104291

Annual Return

-50%0%+50%

Risk level

110

0.80%EUR 10.02

Power Corp of Canada

Power Corp of Canada Valor: 697834

Annual Return

-50%0%+50%

Risk level

110

0.00%CAD 69.00

CI Financial Corp

CI Financial Corp Valor: 4909958

Annual Return

-50%0%+50%

Risk level

110

0.00%CAD 31.99

SIX

FactSet

Clearbit

Logos provided by Clearbit